Open AccessAbstract 3783: Effective MEK inhibitor combinations to target tumor heterogeneity inEGFRmutant transformed SCLC
Author(s) -
Atsuko Ogino,
Xinmeng Jasmine Mu,
Mika Lin,
Antonio Calles,
Stephen Wang,
Man Xu,
Lynette M. Scholl,
Geoffrey R. Oxnard,
Paul T. Kirschmeier,
Pasi A. Jänne
Publication year - 2019
Language(s) - Uncategorized
Resource type - Conference proceedings
DOI - 10.1158/1538-7445.sabcs18-3783
Subject(s) - mek inhibitor , tumor heterogeneity , cancer research , medicine , chemistry , cancer , mapk/erk pathway , kinase , biochemistry